Structure-activity relationship studies on potential non-nucleoside DABO-like inhibitors of HIV-1 reverse transcriptase

Antiviral Chemistry and Chemotherapy

Volumn 11, Issue 2, 2000, Pages 117-133

  Costi, Roberta ^a   Di Santo, Roberto ^a   Artico, Marino ^a   Massa, Silvio ^b   Lavecchia, Antonio ^c   Marceddu, Tiziana ^d   Sanna, Laura ^d   La Colla, Paolo ^d   Marongiu, Maria Elena ^d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

DABO derivatives; HEPT like derivatives; NNRTIs; Pyrimidine derivatives

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CYTOSINE DERIVATIVE; EMIVIRINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; URACIL DERIVATIVE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; DRUG TARGETING; ENZYME ASSAY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

EID: 0034017027     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020001100204     Document Type: Article

References (27)

1. Althaus IW, Chou K-C, Lemay RJ, Franks KM, Deibel MR, Kezdy FJ, Resnick L, Busso ME, So AG, Downey KM, Romero DL, Thomas RC, Aristoff PA, Tarpley WG & Reusser F (1996) The benzylthio pyrimidine U-31,355, a potent inhibitor of HIV-1 reverse transcriptase. Biochemical Pharmacology 51:743-750.
2. Artico M, Massa S, Mai A, Marongiu ME, Piras G, Tramontano E & La Colla P (1993) 3,4-Dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs): a new class of specific inhibitors of human immunodeficiency virus type 1. Antiviral Chemistry & Chemotherapy 4:361-368.
3. Baba M, Tanaka H, De Clercq E, Pauwels R, Balzarini J, Schols D, Nakashima H, Perno CF, Walker RT & Miyasaka T (1989) Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative. Biochemical and Biophysical Research Communications 165:1375-1381.
4. Baba M, De Clercq E, Tanaka H, Ubasawa M, Takashima H, Sekiya K, Nitta I, Umazu K, Walker RT, Mori S, Ito M, Shigeta S & Miyasaka T (1991) Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives. Molecular Pharmacology 39:805-810.
5. Baba M, Shigeta S, Tanaka H, Miyasaka T, Ubasawa M, Umazu K, Walker RT, Pauwels R & De Clercq E (1992) Highly potent and selective inhibition of HIV-1 replication by 6-phenylthiouracil derivatives. Antiviral Research 17:245-264.
6. Baba M, Shigeta S, Yuasa S, Takashima H, Sekiya K, Ubasawa M, Tanaka H, Miyasaka T, Walker RT & De Clercq E (1994) Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro. Antimicrobial Agents and Chemotherapy 38:688-692.
7. Bernstein FC, Koetzle TF, Williams GJB, Meyer Jr EF, Brice MD, Rodgers JR, Kennard O, Shimanouchi T & Tasumi T (1977) The protein data bank: a computer based archival file for macromolecular structures. Journal of Molecular Biology 112:535-542.
8. Clark M, Cramer RDIII & Van Opdenbosch N (1989) Validation of the general purpose Tripos 5.2 force field. Journal of Computational Chemistry 10:982-1012.
9. Delia TJ, Stark D & Glenn SK (1995) 2,4,6-Trichloropyrimidine. Reaction with ethanolamine and diethanolamine. Journal of Heterocyclic Chemistry 32:1177-1180.
10. Gasteiger J & Marsili M (1980) Iterative partial equalization of orbital electronegativity. Tetrahedron 36:3219-3228.
11. Hopkins AL, Ren J, Esnouf RM, Willcox BE, Jones EY, Ross C, Miyasaka T, Walker RT, Tanaka H, Stammers DK & Stuart DI (1996) Complexes of HIV-1 reverse transcriptase inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors. Journal of Medicinal Chemistry 39:1589-1600.
12. Massa S, Di Santo R, Costi R, Artico M, Loi AG, Doa M, Scano P & La Colla P (1994) Synthesis of novel HEPT analogues with anti-HIV-1 activity. Medicinal Chemistry Research 4:554-562.
13. Massa S, Mai A, Artico M, Sbardella G, Tramontano E, Loi AG, Scano P & La Colla P (1995) Synthesis and antiviral activity of a new 3,4-dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs), specific inhibitors of human immunodeficiency virus type 1. Antiviral Chemistry & Chemotherapy 6:1-8.
14. Mai A, Artico M, Sbardella G, Massa S, Loi AG, Tramontano E, Scano P & La Colla P (1995a) Synthesis and anti-HIV-1 activity of thio analogues of dihydroalkoxybenzyloxopyrimidines. Journal of Medicinal Chemistry 38:3258-3263.
15. Mai A, Artico M, Sbardella G, Quartarone S, Massa S, Loi AG, De Montis A, Scintu F, Putzolu M & La Colla P (1995b) Dihydro(alkylthio)(naphtylmethyl)oxopyrimidines: novel non-nucleoside reverse transcriptase inhibitors of the S-DABO series. Journal of Medicinal Chemistry 38:1447-1454.
16. Mai A, Artico M, Sbardella G, Massa S, Novellino E, Greco G, Loi AG, Tramontario E., Marongiu ME & La Colla P (1999) 5-Alkyl-2-alkylthio-6-(2,6-dihalophenylmethyl)-3,4-dihydropyrimidin-4(3H)-ones. Journal of Medicinal Chemistry 42:619-627.
17. Miyasaka T, Tanaka H, Baba M, Hayakawa H, Walker RT, Balzarinin J & De Clercq E (1989) A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine. Jounal of Medicinal Chemistry 32:2507-2509.
18. Nitta Y & Okui K (1963) 2,6-Dialkoxy-4-aminopyrimidines. Japan 10,336 (1962); Chemical Abstracts 59:P5177d.
19. Pauwels R, Balzarini J, Baba M, Snoeck R, Schols D, Herdewijn P, DesmysterJ & De Clercq E (1988) Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. Journal of Virological Methods 20:309-321.
20. Purcel VP & Singer JA (1967) A brief review and table of semiempirical parameters used in the Hückel molecular orbital method. Journal Chemical Engineering Data 12:235-246.
21. Ren J, Esnouf R, Garman E, Somers D, Ross C, Kirby I, Keeling J, Darby G, Jones Y, Stuart D & Stammers D (1995) High resolution structures of HIV-1 RT from four RT-inhibitor complexes. Nature Strucural Biology 2:293-302.
22. Tanaka H, Baba M, Saito S, Miyasaka T, Takashima H, Sekiya K, Ubasawa M, Nitta I, Walker RT, Nakashima H & De Clercq E (1991a) Specific anti-HIV-1 'acyclonucleosides' which cannot be phosphorilated: synthesis of some deoxyanalogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine. Journal of Medicinal Chemistry 34:1508-1511.
23. Tanaka H, Baba M, Ubasawa M, Takashima H, Sekiya K, Nitta I, Shigeta S, Walker RT, De Clercq E & Miyasaka T (1991b) Synthesis and anti-HIV activity of 2-, 3-, and 4-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). Journal of Medicinal Chemistry 34:1394-1399.
24. Tanaka H, Baba M, Hayakawa H, Sakamaki T, Miyasaka T, Ubasawa M, Takashima H, Sekiya K, Nitta I, Shigeta S, Walker RT, Balzarini J & De Clercq E (1991c) A new class of HIV-1-specific 6-substituted acyclouridine derivatives: synthesis and anti-HIV-1 activity of 5-or 6-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). Journal of Medicinal Chemistry 34:349-357.
25. Tanaka H, Takashima H, Ubasawa M, Sekiya K, Nitta I, Baba M, Shigeta S, Walker RT, De Clercq E & Miyasaka T (1992a) Structure-activity relationships of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine analogues; effect of substituents at the C-6 phenyl ring and at the C-5 position on anti-HIV-1 activity. Journal of Medicinal Chemistry 35:337-345.
26. Tanaka H, Takashima H, Ubasawa M, Sekiya K, Nitta I, Baba M, Shigeta S, Walker RT, De Clercq E & Miyasaka T (1992b) Synthesis and antiviral activity of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti HIV-1 agents. Journal of Medicinal Chemistry 35:4713-4719.
27. Tsuji T, Watanabe S, Nakadai Y & Toyoshima S (1962) Synthesis and antimicrobial activity of N-(2-alkylthio-6-alkoxy-4-pyrimidinyl)sulfanilamide. Chemical & Pharmaceutical Bulletin 10:9-13.